Endocrinology

Top Story

First automated insulin-delivery device approved for type 1 diabetes

September 28, 2016

The FDA today approved Medtronic’s MiniMed 670G, the first hybrid closed loop system — often referred to as an “artificial pancreas” — designed to monitor glucose and provide appropriate insulin doses for people aged 14 years and older with type 1 diabetes, according to an FDA press release.

‘The FDA is dedicated to making technologies available that can help improve the quality of life for those with chronic diseases — especially those that require day-to-day maintenance and ongoing attention,” Jeffrey Shuren, MD, JD, director of the FDA’s Center for Devices and Radiological Health, said in the release. “This first-of-its-kind technology can provide people with type 1 diabetes greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin.”

In the Journals Plus

Stroke risk increases with low-normal TSH levels

September 28, 2016
Patients with thyroid-stimulating hormone levels within the upper limit of the reference range have a lower risk for stroke compared with those whose levels are nearer…

NIH funds trial of chelation therapy for patients with diabetes, prior MI

September 28, 2016
Mount Sinai Medical Center of Florida announced that it and Duke Clinical Research Institute have received an NIH grant of $37 million to fund a second study of IV…
Health Care Legislative and Regulatory Update

Pay careful attention regarding evaluation and management services and the global surgery period

September 28, 2016
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
In the Journals Plus

GLP-1 receptor agonist, DPP-IV inhibitor alter bile acids

September 28, 2016
Liraglutide may alter the intestinal microbiome, whereas sitagliptin may increase hepatic bile acid production in adults with type 2 diabetes, study data show. Mark M
More News Headlines »
CME

Practical Lipidology®: Volume 3, Number 1

This activity is supported by an educational grant from Amgen

The reduction of low-density lipoprotein-cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Video
Meeting News Coverage

VIDEO: Less surgery, active surveillance viable option for low-risk thyroid cancer

September 22, 2016
More »
Featured
ATA 2016

ATA 2016

CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
in the journals

Get the best of the journals.
Read abstracts, search and filter results, gain perspective, view graphics.

Go »
Current Issues
View the Current Issues
morganatic-roan